NL7504387A - Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking. - Google Patents

Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking.

Info

Publication number
NL7504387A
NL7504387A NL7504387A NL7504387A NL7504387A NL 7504387 A NL7504387 A NL 7504387A NL 7504387 A NL7504387 A NL 7504387A NL 7504387 A NL7504387 A NL 7504387A NL 7504387 A NL7504387 A NL 7504387A
Authority
NL
Netherlands
Prior art keywords
unsubstituted
alkyl
dermatophytic
procedure
preparation
Prior art date
Application number
NL7504387A
Other languages
English (en)
Dutch (nl)
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19742418502 external-priority patent/DE2418502C3/de
Priority claimed from DE19752510130 external-priority patent/DE2510130A1/de
Priority claimed from DE19752510781 external-priority patent/DE2510781A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of NL7504387A publication Critical patent/NL7504387A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/37—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL7504387A 1974-04-11 1975-04-11 Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking. NL7504387A (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19742418502 DE2418502C3 (de) 1974-04-11 1974-04-11 Dichlorbenzyl- [2-( a -imidazolylbutyl)-phenyl] -äther und -thioäther, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19752510130 DE2510130A1 (de) 1975-03-06 1975-03-06 Imidazolderivate und verfahren zu ihrer herstellung
DE19752510781 DE2510781A1 (de) 1975-03-07 1975-03-07 Imidazolderivate und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
NL7504387A true NL7504387A (nl) 1975-10-14

Family

ID=27185894

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7504387A NL7504387A (nl) 1974-04-11 1975-04-11 Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking.

Country Status (17)

Country Link
US (1) US4006243A (xx)
JP (1) JPS6018654B2 (xx)
AT (1) AT341518B (xx)
CA (1) CA1051908A (xx)
CH (1) CH612185A5 (xx)
CS (1) CS194221B2 (xx)
DD (1) DD121515A5 (xx)
DK (1) DK139909C (xx)
ES (1) ES436546A1 (xx)
FR (1) FR2267101B1 (xx)
GB (1) GB1510016A (xx)
HU (1) HU172895B (xx)
IE (1) IE40911B1 (xx)
IL (1) IL47061A (xx)
NL (1) NL7504387A (xx)
SE (1) SE418498B (xx)
YU (1) YU89875A (xx)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT328587B (de) * 1973-08-20 1976-03-25 Vianova Kunstharz Ag Verfahren zur herstellung von wasserigen uberzugsmitteln
US4237158A (en) * 1975-02-05 1980-12-02 Rohm And Haas Company 1-Substituted aralkyl imidazoles and their use as fungicides
DE2549798C3 (de) * 1975-11-06 1978-06-29 Nordmark-Werke Gmbh, 2000 Hamburg 1,2-Dipheny l-3-(imidazo Wl-1 )propene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel
US4118461A (en) * 1975-12-18 1978-10-03 Rohm And Haas Company 1-Substituted aralkyl imidazoles
US4115578A (en) * 1975-12-18 1978-09-19 Rohm And Haas Company 1-Substituted aralkyl imidazoles
DE2732750A1 (de) * 1977-07-20 1979-02-08 Merck Patent Gmbh Basische thioaether und verfahren zu ihrer herstellung
US4284641A (en) * 1977-08-26 1981-08-18 Burroughs Wellcome Co. Pharmaceutically active imidazole derivatives
US4431815A (en) * 1977-08-26 1984-02-14 Burroughs Wellcome Co. 1-[3-(2,4-Dichlorophenyl)propyl]imidazole and salts thereof
US4396771A (en) * 1977-10-19 1983-08-02 Burroughs Wellcome Co. Imidazole derivatives and salts thereof
IT1097314B (it) * 1978-07-26 1985-08-31 Recordati Chem Pharm Derivati dell'imidazolo ad attivita' anticonvulsivante
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
DK531479A (da) * 1979-01-19 1980-07-20 Pfizer Fremgangsmaade til fremstilling af imidazolderivater og salte deraf
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
US4218461A (en) * 1979-08-15 1980-08-19 E. R. Squibb & Sons, Inc. 2,3-Dihydro-2-[(1H-imidazol-1-yl)-methylene]-1H-inden-1-ones
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
CA1156661A (en) * 1980-02-25 1983-11-08 Hoffmann-La Roche Limited Phenoxy-aminopropanol derivatives
WO1982001819A1 (en) * 1980-12-05 1982-06-10 Strehlke Peter Antidandruff agent
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
JPS58150566A (ja) * 1982-03-03 1983-09-07 Yoshitomi Pharmaceut Ind Ltd 新規イミダゾ−ル誘導体
ES523609A0 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB2126218B (en) * 1982-08-14 1986-01-22 Wellcome Found Imidazoles
JPS60142965A (ja) * 1983-09-05 1985-07-29 Yoshitomi Pharmaceut Ind Ltd イミダゾ−ル誘導体の製造法
EP0149976A3 (de) * 1983-12-30 1986-12-10 Ciba-Geigy Ag Substituierte Imidazole
US4755526A (en) * 1984-06-18 1988-07-05 Eli Lilly And Company Method of inhibiting aromatase
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5459145A (en) * 1988-01-19 1995-10-17 Pfizer Inc. Calcium independent camp phosphodiesterase inhibitor antidepressant
HU215433B (hu) * 1986-04-29 2000-05-28 Pfizer Inc. Eljárás új 2-oxo-5-fenil-pirimidin-származékok előállítására
US5214064A (en) * 1987-05-02 1993-05-25 Basf Aktiengesellschaft Phenoxyphenylmethyl substituted azoles and pesticidal composition thereof
US5280036A (en) * 1987-05-02 1994-01-18 Basf Aktiengesellschaft N-phenoxyphenyloxymethyl substituted azoles and method for controlling pests therewith
CA1329614C (en) * 1987-05-02 1994-05-17 Rainer Buerstinghaus N-substituted azoles
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
ZA923283B (en) * 1991-05-29 1993-01-27 Akzo Nv Phenoxyphenyl derivatives
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
WO1995029163A1 (fr) * 1994-04-27 1995-11-02 Nippon Soda Co., Ltd. Derive d'imidazole et procede de production de ce derive
US5922751A (en) * 1994-06-24 1999-07-13 Euro-Celtique, S.A. Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same
DE19541146A1 (de) * 1995-10-25 1997-04-30 Schering Ag Imidazolderivate und deren Verwendung als Stickstoffmonoxid-Synthase-Inhibitoren
US6297239B1 (en) 1997-10-08 2001-10-02 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
US6284755B1 (en) 1998-12-08 2001-09-04 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
AU2001230864A1 (en) 2000-01-12 2001-07-24 Merck And Co., Inc. Inhibitors of prenyl-protein transferase
EP1178038A1 (en) * 2000-08-04 2002-02-06 Aventis Cropscience S.A. Fungicidal phenylamidine derivatives
US7553837B2 (en) 2003-08-01 2009-06-30 Nippon Soda Co., Ltd. Phenylazole compounds production process and antioxidants
NZ595073A (en) 2009-04-20 2012-11-30 Hoffmann La Roche Proline derivatives as cathepsin inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1908991B2 (de) * 1969-02-22 1977-05-26 Bayer Ag, 5090 Leverkusen Alpha, alpha-disubstituierte n- benzylimidazole und deren salze
DE2007794A1 (de) * 1970-02-20 1971-09-02 Farbenfabriken Bayer Aktiengesell schaft, 5090 Leverkusen Fungizide Mittel
US3833603A (en) * 1970-04-09 1974-09-03 Bayer Ag 1-(alpha,alpha-disubstituted 4-phenoxy-benzyl)imidazoles
NL7108387A (xx) * 1970-06-22 1971-12-24 Koninklijke Pharma Fab Nv
US3927017A (en) * 1974-06-27 1975-12-16 Janssen Pharmaceutica Nv 1-({62 -Aryl-{62 -R-ethyl)imidazoles

Also Published As

Publication number Publication date
DK153075A (xx) 1975-10-12
IE40911L (en) 1975-10-11
YU89875A (en) 1982-05-31
IL47061A (en) 1978-08-31
CH612185A5 (xx) 1979-07-13
FR2267101B1 (xx) 1980-01-25
DK139909B (da) 1979-05-14
SE7504123L (sv) 1975-12-19
AU8002575A (en) 1976-10-14
DD121515A5 (xx) 1976-08-05
ES436546A1 (es) 1977-01-16
FR2267101A1 (xx) 1975-11-07
JPS6018654B2 (ja) 1985-05-11
GB1510016A (en) 1978-05-10
IL47061A0 (en) 1975-06-25
JPS50148357A (xx) 1975-11-27
SE418498B (sv) 1981-06-09
US4006243A (en) 1977-02-01
IE40911B1 (en) 1979-09-12
AT341518B (de) 1978-02-10
ATA268675A (de) 1977-06-15
HU172895B (hu) 1978-12-28
CA1051908A (en) 1979-04-03
CS194221B2 (en) 1979-11-30
DK139909C (da) 1979-10-08

Similar Documents

Publication Publication Date Title
NL7504387A (nl) Werkwijze voor de bereiding van een genees- middel met onder meer anti-dermatofytische en anti-bacterien-werking.
NL168509C (nl) Werkwijze ter bereiding van een therapeutisch preparaat, alsmede werkwijze ter bereiding van daarvoor geschikte verbindingen.
KR910006218A (ko) 2-아미도테트라린 치환유도체와 이 치환유도체를 포함하는 제약학적 조성물 및 이를 사용한 치료방법
BR9908764A (pt) Composto e seus sais farmaceuticamente aceitáveis ou ésteres hidrolisáveis in vivo, uso destes, processo para prepará-los, e, composição farmacêutica
KR910006200A (ko) 퀴논 유도체 및 약리학적 이용
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
KR960004344A (ko) 6원 질소 함유 헤테로아릴-옥사졸리디논
NL930018I2 (nl) (Piperidinylalkyl) chinazolinederivaten, werkwijzen voor hun bereiding en farmaceutische preparaten die ze bevatten.
DK568187A (da) Transdermal flux-foroegende praeparat
KR900009606A (ko) 불소-함유 2-니트로 이미다졸 유도체 및 그를 함유하는 방사선 증감제
KR880012532A (ko) 신규 비시클릭화합물, 그의 제조방법 및 이 화합물로 되는 제약조성물
DE3576075D1 (de) 5-alkyl-1-phenyl-2-piperazinoalkylpyrazolin-3-on-verbindungen sowie verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
DK0531419T3 (da) Bistriazener som kemoterapeutiske midler
KR900001715A (ko) Bu-3608 유도체
GB1185096A (en) Improvements in or relating to Antibiotic Derivatives and the manufacture thereof
FR2446829A1 (fr) Derives de polymethylene disubstitues en alpha, omega, procede pour leur preparation et compositions pharmaceutiques les contenant
GB1289240A (xx)
KR890003692A (ko) 1.2.5.6- 테트라히드로피리딘-3-카르복스알데히드의 옥심유도체, 이들의 제조방법, 약제로서의 이들의 용도 및 이들을 함유하는 조성물
KR900007808A (ko) 1,2,3,4-테트라하이드로-1,9-아크리딘디아민, 이의 제조방법 및 이의 약제로서의 용도
DE60031699D1 (de) Hydroxyacetamidobenzolsulfonamidderivate
KR880007490A (ko) 치환된 아미노프로피온아미드, 이의 제조방법, 이를 함유하는 약제, 이의 용도 및 이의 제조시에 생성된 중간체
KR880004810A (ko) 소화성 궤양 치료제
FR2421181A1 (fr) Derives de substitution de spirooxazolidinone steroidienne, leur procede de preparation et compositions pharmaceutiques les contenant
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
KR870004038A (ko) 제초제 화합물의 제조방법

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed